PRIMOLUT DEPOT Amp 250 mg

Land: Jordanien

Språk: engelska

Källa: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Bipacksedel Bipacksedel (PIL)
07-03-2024

Aktiva substanser:

Hydroxyprogesterone Caproate 250 mg

Tillgänglig från:

شركة مستودع الأدوية الأردني - The Jordan Drugstore Co

ATC-kod:

G03DA03

INN (International namn):

Hydroxyprogesterone Caproate 250 mg

Dos:

250 mg

Enheter i paketet:

1 X 1ml Ampoule

Tillverkad av:

Bayer AG (المانيا)

Produktsammanfattning:

2.67 :سعر الجمهور + الضريبة

Bipacksedel

                                LAYOUT MANAGEMENT PEWI
Seite 
Bayer Schering Pharma
Mandant: 0031
Stoff-Nr.: 80875003/0609
PZ: 2514F-4
Code-Nr.: 453
Bezeichnung: LF-PRIMOLUT N 5MG
Aufmachung: SAUA BSP
Farben: BLACK
Version: 19.06.2009/01
Freigabe:
PROFESSIONAL DATASHEET
SUMMARY OF PRODUCT CHARACTERISTICS
THIS IS A MEDICAMENT
A medicament is a product which affects your health and its
consumption contrary to instructions is dangerous for you.
Follow strictly the doctor‘s prescription, the method of use and
the
instructions of the pharmacist who sold the medicament.
The doctor and the pharmacist are experts in medicine, its benefits
and risks.
Do not by yourself interrupt the period of treatment prescribed.
Do not repeat the same prescription without consulting your doctor.
Keep medicament out
of reach of children
Council of Arab Health Ministers
Union of Arab Pharmacists
1. NAME OF THE MEDICINAL PRODUCT
Primolut Depot 250 mg ampoules
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
One 1-ml ampoule contains 250 mg hydroxyprogesterone caproate.
Other constituents: 517.7 mg benzyl benzoate, 297.3 mg castor oil
for injection
See section entitled “List of other constituents“ for a full list
of the
other constituents.
3. DOSAGE FORM
Oily, pale yellow solution for injection, free of particles
4. CLINICAL PARTICULARS
4.1 INDICATIONS
Habitual and threatened abortion due to corpus luteum deficiency
4.2 DOSAGE, MODE AND DURATION OF EMPLOYMENT
Like all oily solutions Primolut Depot 250 mg must be injected via the
intramuscular route. Experience has shown that the transient patient
reactions that occur in rare cases during or immediately after the
injection of oily solutions (urge to cough, coughing bouts, shortness
of breath) can be prevented by injecting particularly slowly.
DOSAGE:
In line with the latest scientific knowledge any medicinal therapy
in early pregnancy requires an unequivocal indication. This applies
similarly to the use of hormonal preparations like Primolut Depot
to maintain pregnancy. Consequently, Primolut Depot must on
                                
                                Läs hela dokumentet
                                
                            

Sök varningar relaterade till denna produkt